Clinical trial
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
NCT00110487 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00110487 |
|---|---|
| Title | Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study of the Effect of ERB-041 in the Reduction of Symptoms Associated With Endometriosis in Reproductive-Age Women |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | ERB-041 |
| Enrollment | 200 |
| Start date | Jan 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | May 10, 2005 |
| Last update posted | May 1, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: